 | Study programme 2025-2026 | Français | |
 | Analyses critiques d'études cliniques | ||
Programme component of Master's in Pharmacy (MONS) (day schedule)Faculty of Medicine, Pharmacy and Biomedical Sciences |
| Code | Type | Head of UE | Department’s contact details | Teacher(s) |
|---|---|---|---|---|
| UM-M2-PHARMA-033-M | Optional UE | CATTEAU Lucy | M101 - FMPB - Service du Doyen |
|
| Language of instruction | Language of assessment | HT(*) | HTPE(*) | HTPS(*) | HR(*) | HD(*) | Credits | Weighting | Term |
|---|---|---|---|---|---|---|---|---|---|
| Français | 10 | 0 | 0 | 0 | 0 | 1 | 1.00 | 1st term |
| AA Code | Teaching Activity (AA) | HT(*) | HTPE(*) | HTPS(*) | HR(*) | HD(*) | Term | Weighting |
|---|---|---|---|---|---|---|---|---|
| M-DOYM-229 | Analyses critiques d'études cliniques | 10 | 0 | 0 | 0 | 0 | Q1 | 100.00% |
| Programme component |
|---|
Objectives of Programme's Learning Outcomes
Learning Outcomes of UE
- Search for the best available evidence to solve a clinical problem (EBM or Evidence-based medicine).
- Evaluate the available information and determine the value to be attributed to data from the scientific literature and other relevant sources of information (critical analysis).
- Understand the concept of therapeutic guidelines and how they should or not be implemented in daily practice.
UE Content: description and pedagogical relevance
The principles of the Evidence-based medicine are presented in two chapters:
- Primary sources (experimental and observational studies)
- Secondary and tertiary sources (systematic reviews and meta-analyses; treatment guidelines and consensus meetings; other sources of information)
For each of the sources described in these chapters, we will discuss the different types of studies that can be used, the methods for expressing the results, the sources of information and the criteria for critical analysis.
Prior Experience
Not applicable
Type of Teaching Activity/Activities
| AA | Type of Teaching Activity/Activities |
|---|---|
| M-DOYM-229 |
|
Mode of delivery
| AA | Mode of delivery |
|---|---|
| M-DOYM-229 |
|
Required Learning Resources/Tools
| AA | Required Learning Resources/Tools |
|---|---|
| M-DOYM-229 | Not applicable |
Recommended Learning Resources/Tools
| AA | Recommended Learning Resources/Tools |
|---|---|
| M-DOYM-229 | Not applicable |
Other Recommended Reading
| AA | Other Recommended Reading |
|---|---|
| M-DOYM-229 | Not applicable |
Grade Deferrals of AAs from one year to the next
| AA | Grade Deferrals of AAs from one year to the next |
|---|---|
| M-DOYM-229 | Authorized |
Term 1 Assessment - type
| AA | Type(s) and mode(s) of Q1 assessment |
|---|---|
| M-DOYM-229 |
|
Term 1 Assessment - comments
| AA | Term 1 Assessment - comments |
|---|---|
| M-DOYM-229 | The assessment of prior learning has 2 components: 1. Participation to the lectures and the results of exercises carried out during the courses and/or online are worth 2/20. 2. A written exam with theoretical and practical questions related to the different parts of the course is worth 18/20. |
Resit Assessment - Term 1 (BAB1) - type
| AA | Type(s) and mode(s) of Q1 resit assessment (BAB1) |
|---|---|
| M-DOYM-229 |
|
Resit Assessment - Term 1 (BAB1) - Comments
| AA | Resit Assessment - Term 1 (BAB1) - Comments |
|---|---|
| M-DOYM-229 | The remedial evaluation will be done in the same way as the initial evaluation. |
Term 3 Assessment - type
| AA | Type(s) and mode(s) of Q3 assessment |
|---|---|
| M-DOYM-229 |
|
Term 3 Assessment - comments
| AA | Term 3 Assessment - comments |
|---|---|
| M-DOYM-229 | The remedial evaluation will be done in the same way as the initial evaluation. |